Both capillary (fingerstick) and venous samples are supported per local labeling.

iMOST demonstrates lab-comparable agreement with high-end central lab analyzers. Clinical studies show strong correlation across CBC parameters, including HGB (r≈0.99) and WBC (r≈0.99).

The workflow is designed to be simple:

• One Q-card
• One press
• One insertion

Usability studies indicate that operators—including elderly patients under supervised settings—can use the system with minimal training.

Each test requires approximately 10 µL of blood applied to the Q-Card.

For iMOST-L, direct finger-to-card transfer is supported. If there will be a delay before testing, collecting the sample in an Essenlix-recommended K2EDTA tube is recommended to help maintain sample integrity.

For iMOST-U, it is recommended to collect capillary blood into an Essenlix-recommended K2EDTA tube (approx. 100 µL) prior to testing.

Before Test: Charge the system to greater than 30% battery or plug-in.

After Test: Clean the exterior surface of iMOST L with disinfectant reagent, or as required.

Note: after wiping, please clean up the liquid residual with tissue.

Essenlix’s iMOST is an instant personal, mobile, health self-testing platform that uses unique technology innovations. iMOST allows an individual to perform health tests easily, quickly, accurately, and affordably anywhere, anytime, with results in minutes that can be sent immediately to a healthcare professional. With the potential to do various tests of different biomarkers in different body fluids with different biochemistries, the first application of iMOST is hematology analyzer, CBC or complete blood count is a vital sign of a person’s health, and one of the most common but important lab tests.

Hemoglobin (HGB), White Blood Cell Count (WBC), neutrophil percentage (NEU%), lymphocyte percentage (LYM%), monocyte percentage (MON%), eosinophil percentage (EOS%), basophil percentage (BAS%), neutrophil count (NEU#), lymphocyte count (LYM#), monocyte count (MON#), eosinophil count (EOS#), and basophil count (BAS#).

iMOST has a number of advantages over traditional diagnostic technologies
·Mobile, personal use anywhere, anytime, no need for professionals
·Fast (many tests within minute), accurate, and easy-to-use
·Small, lightweight with portable reader
·Powered by the battery — no external power source required
·No liquid reagents required (dry reagents all contained on test card)
·No daily control and calibration required
·Low cost